HIF1A and neoplasm: Furthermore, the adenosine-generating ectoenzymes CD39 and CD73 are regulated by HIF1A and have been shown to promote tumor growth, invasiveness, and metastatic potential, resulting in poor clinical outcomes (8, 9, 16–20, 28, 29, 35, 36, 42).